Why Independence Matters in Pharmacy Review | IMM

Why Independence Matters in Pharmacy Review

Pharmacy reviews that rely on dispensing pharmacists encounter structural conflicts of interest. Independent review identifies medication risks that biased reviews systematically miss.

Published 3 April 2026

Understanding Conflicts of Interest in Pharmacy Review

Your insurance claims require pharmacy review that prioritizes your claimant's medication outcomes. However, many pharmacy reviews come from clinicians with competing financial interests. Understanding these conflicts is essential for recognizing when reviews may be biased.

This isn't about suggesting dishonesty. Clinical professionals generally act with integrity. The issue is structural: when a pharmacy's revenue depends on dispensing specific medications, that pharmacy's incentive to review those medications is compromised. This creates systematic bias that affects review quality regardless of individual pharmacist intentions.

The Dispensing Pharmacy Conflict of Interest

Consider your claimant's medications are dispensed by a community pharmacy. That pharmacy receives revenue for each item dispensed. When reviewing your claimant's medication list, the dispensing pharmacy faces a fundamental conflict:

  • Recommending medication discontinuation reduces pharmacy revenue.
  • Recommending medication switches may redirect revenue to different products.
  • Identifying medication problems could lead to clinical change that reduces dispensing.
  • Maintaining status quo protects existing revenue streams.

Most community pharmacies operate with reasonable profit margins. Your claimant's medications may represent meaningful revenue. This creates a structural incentive to support medication continuity, even when medication changes would improve your claimant's outcomes.

The Core Issue: When the pharmacy conducting your medication review profits from dispensing, their recommendation to continue medications is systemically biased, regardless of clinical merits.

How Structural Bias Manifests in Reviews

The conflict of interest in dispensing pharmacy reviews creates predictable patterns:

Minimising Medication Problems

Dispensing pharmacies tend to characterise medication concerns as manageable rather than problematic. Your claimant on three different medications for the same condition might be told "this is acceptable" rather than "this represents polypharmacy requiring urgent review." The distinction matters for your claim outcomes.

Emphasising Prescriber Authority

Dispensing pharmacy reviews frequently defer to prescriber judgment: "The doctor has prescribed this, so it must be appropriate." This stance protects revenue by avoiding recommendations that contradict prescribers. It also avoids the uncomfortable conversation where the pharmacy questions the prescribing that generates its revenue.

Accepting Medication Accumulation

Your claimant's medication list grows over time as providers add medications without discontinuing previous ones. Dispensing pharmacies tend to accept this accumulation passively. Independent review actively questions whether each medication remains necessary, directly threatening revenue if medications are ceased.

Avoiding Difficult Conversations

Recommending medication cessation or significant dose reduction requires difficult conversations with prescribers. Dispensing pharmacies avoid these conflicts when possible. This reflects rational business incentives, not poor clinical practice.

Preferring High-Margin Products

When multiple medication options exist, dispensing pharmacies may subtly prefer higher-margin products. Your claimant may be dispensed a premium version of a medication class when a more cost-effective equivalent exists. Independence allows review to recommend the most clinically appropriate option regardless of pharmacy margin.

Specific Areas Where Bias Emerges

Pharmacy conflicts of interest particularly affect reviews of:

Polypharmacy and Deprescribing

Your claimant on ten medications benefits from systematic deprescribing. Dispensing pharmacies are systematically biased against deprescribing recommendations because discontinuation reduces revenue. Independent review actively seeks deprescribing opportunities.

High-Cost Medications

Your claimant on expensive branded medications may continue indefinitely in biased review despite generic equivalents existing. Independent review recommends cost-effective switches that dispensing pharmacies implicitly avoid.

Medication Interactions and Appropriateness

Complex medication interactions require clear recommendation for prescriber consultation or medication change. Dispensing pharmacies may characterise interactions as manageable when independent review would escalate concerns. The difference reflects financial incentives, not clinical knowledge.

Medication-Related Harms

When your claimant's medication causes falls, cognitive impairment, or other harm, dispensing pharmacies face subtle pressure to minimise the medication's role. Stating clearly that "this medication is harming your claimant" directly challenges the prescribing that generates revenue.

Why Independence Changes Everything

Independent pharmacy review removes these structural conflicts. When your reviewer earns no revenue from dispensing, several things change fundamentally:

Clear-Eyed Problem Identification

Independent reviewers identify medication problems without fear that the identification will reduce revenue. Your claimant on four pain medications for the same condition receives a clear assessment: "this is problematic polypharmacy requiring urgent prescriber consultation."

Deprescribing Becomes Standard Practice

Independent review asks "which medications can be safely ceased?" as a core question. Dispensing pharmacies ask this reluctantly. Your claimant benefits from systematic reduction of unnecessary medications.

Difficult Clinical Conversations Happen

When a medication is harming your claimant, independent review recommends discontinuation without hedging. "This medication is causing falls; it should be ceased" is a clear recommendation. Dispensing pharmacy reviews often communicate the same concern more indirectly.

Cost-Effectiveness Drives Recommendations

Independent review can recommend switching from branded to generic medications, or from expensive classes to cheaper alternatives, when clinical outcomes are equivalent. Dispensing pharmacies have subtle incentive to maintain expensive products.

Prescriber Communication is Direct

Independent reviewers communicate clinical concerns directly to prescribers. "Your medication regimen requires deprescribing" is a clear message without the diplomatic softening that dispensing pharmacies employ.

Independence in pharmacy review isn't about competence. Dispensing pharmacists are highly qualified. Independence matters because it removes systematic financial incentives that subtly bias recommendations toward medication continuation.

The Evidence for Bias in Non-Independent Review

Research consistently shows that reviews conducted by stakeholders with financial interest produce systematically different results than independent review:

  • Dispensing pharmacies identify fewer medication problems than independent reviewers examining the same medication list.
  • Recommendations for medication cessation are less frequent when the reviewer profits from dispensing.
  • Characterisation of medication appropriateness is more favorable when revenue is at stake.
  • High-cost medications are recommended to continue more frequently in financially-conflicted review.

These differences reflect rational financial incentives, not incompetence or dishonesty. The bias is structural, not individual.

What to Look for in Independent Review

When assessing whether your pharmacy review is truly independent, look for these indicators:

Independent Review Characteristic Why It Matters
Reviewer receives no revenue from dispensing Removes financial incentive to recommend medication continuation
Reviewer has no relationship with treating pharmacies Prevents professional pressure to align with primary pharmacist
Reviewer specializes in insurance claims Understands claim-specific issues beyond community pharmacy practice
Direct access to all medical records, not just dispensing data Prevents gaps in clinical understanding that bias review
Clear statement of independence in review report Transparency about potential conflicts or absence thereof
Direct communication with insurers, not through intermediaries Reduces opportunity for filtered or modified recommendations

Implications for Your Claim Management

Understanding bias in pharmacy review affects your claim strategy significantly:

Challenge Optimistic Assessments

When your dispensing pharmacy assesses medication appropriateness as "acceptable," request independent review. Dispensing pharmacies systematically underestimate medication problems. Independent review will frequently identify concerns the dispensing pharmacy minimised.

Prioritise Deprescribing Opportunities

Your claimant's medication list likely contains unnecessary medications that dispensing pharmacies have passively accepted. Independent review specifically asks which medications can be safely ceased, benefiting your claimant and your claims costs.

Ensure Prescriber Engagement

When medication review identifies problems, ensure prescribers understand the clinical rationale for change. Independent reviewers communicate this more clearly than dispensing pharmacies, which have subtle incentive to minimize conflict.

Measure Outcomes, Not Just Recommendations

The value of medication review emerges when recommendations are implemented. Independent reviewers typically have higher prescriber uptake rates because their recommendations are direct, clear, and backed by clinical expertise without financial conflict.

The Cost of Biased Review

Using dispensing pharmacies for medication review costs your organisation in subtle but measurable ways:

  • Unnecessary medications continue, increasing medication costs.
  • Medication problems are identified later than independent review would catch them.
  • Deprescribing opportunities are missed, extending claim duration.
  • Medication-related adverse events that independent review would prevent still occur.
  • Your claimant experiences worse outcomes when medication problems are underestimated.

The bias doesn't require dishonesty. It simply reflects financial incentives that systematically favour medication continuation.

Ensure your medication reviews are truly independent.

IMM's pharmacy team earns no revenue from dispensing, ensuring your reviews identify medication problems without conflict. We work exclusively for insurers, giving your claims access to unbiased clinical expertise.

Request a Medication Review

This article was prepared by the clinical pharmacy team at IMM (Independent Medication Management), Australia's specialist provider of medication reviews for the insurance industry. IMM works with insurers across workers compensation, CTP, life insurance, and NDIS schemes to deliver pharmacist-led medication management that improves claimant outcomes and reduces medication-related risk. Learn more about IMM's services.

Evidence-Based Medication Oversight for Better Claim Outcomes

Expert pharmacy reviews and medication management services that help claims teams make confident, informed decisions about medication-related claims.

Got Questions? Speak to an Independent Pharmacist

Unbiased advice on your claimant's medications and recovery plan.